122111-03-9 - Manufacturers, Suppliers, Factory from China

122111-03-9, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)
Read More

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

tert-Butylhydroquinone (TBHQ) CAS 1948-33-0 Purity >99.5% (GC) Food Antioxidant Factory

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Top Selling Products

Related Blog
Reviews

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

6 October 2021 The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2021 to Benjamin List Max-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany Da...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Yellow phosphorus and phosphoric acid rose together

Yellow phosphorus and phosphoric acid rose together Yunnan-guizhou yellow phosphorus prices rose.Data show that the offer of 34500 yuan/ton at the beginning of the week has risen to 60,000 yuan/to...

2022.11.25 06:42:18
2022.11.25 05:22:22
2022.02.15 15:05:33
2021.12.17 05:10:32
2021.10.30 15:13:54
2021.10.16 11:27:38

122111-03-9 - Manufacturers, Suppliers, Factory from China

Related Products

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

tert-Butylhydroquinone (TBHQ) CAS 1948-33-0 Purity >99.5% (GC) Food Antioxidant Factory

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Top Selling Products

4-Bromothiazole CAS 34259-99-9 Purity >99.0% (GC) Factory High Quality

Boc-Ser(Me)-OH·DCHA CAS 51293-47-1 Assay >98.0% (HPLC)

p-Toluenesulfonamide (PTSA) CAS 70-55-3 Purity >99.5% (HPLC) Factory High Quality

Diflorasone Diacetate CAS 33564-31-7 Assay 97.0~103.0% Factory Corticosteroid

Titanium(IV) Chloride (TiCl4) CAS 7550-45-0 Purity >99.9%

4-Fluorophenyl Acetate (FPA) CAS 405-51-6 Purity >99.5% (GC)

2,5-Dichlorothiophene CAS 3172-52-9 Purity >98.0% (GC) Factory Hot Sale

Phenyl Salicylate CAS 118-55-8 Purity >99.0% (HPLC) Factory

tert-Butyldimethylsilane CAS 29681-57-0 Purity >98.0% (GC) Factory

3,5-Dimethyl-4-hydroxybenzaldehyde CAS 2233-18-3 Factory High Quality

2-Amino-6-Chloro-3-Nitropyridine CAS 27048-04-0 Assay >98.0% (HPLC) Factory High Quality

3-Fluorophenylacetic Acid CAS 331-25-9 Purity >99.0% (HPLC) Factory

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

Paxlovid: what we know about Pfizer's Covid-19 pill

Xi presents award to top scientists

The “Summit on COVID-19 Diagnostics & Treatment”

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Yellow phosphorus and phosphoric acid rose together

2022.11.25 06:42:18

2022.11.25 05:22:22

2022.02.15 15:05:33

2021.12.17 05:10:32

2021.10.30 15:13:54

2021.10.16 11:27:38

related search